Physician profile
Mitchell Eton
NPI 1689358830
$1,920.11
in general payments reported to CMS, 2019-2025
30 companies · $863 in 2025
The $863 reported for 2025 was more than what 84% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $12.69 · 2024: $1,044 · 2025: $863.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,920.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,920.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $233.97 | 2024-2025 | Winrevair, Verquvo, Keytruda |
| Atricure, INC. | $205.60 | 2024-2025 | Atriclip Laa Exclusion System, Synergy Ablation System |
| Scpharmaceuticals INC. | $155.05 | 2024-2025 | |
| Kiniksa Pharmaceuticals International, Plc | $103.88 | 2024 | Arcalyst |
| Kestra Medical Technology Services, INC. | $97.03 | 2025 | Assure Wcd |
| Lexicon Pharmaceuticals, INC. | $90.04 | 2024 | |
| United Therapeutics Corporation | $89.87 | 2024-2025 | Tyvaso, Tyvaso |
| Novo Nordisk INC | $89.39 | 2023-2025 | Ozempic, Rybelsus |
| Baxter Healthcare | $81.71 | 2024-2025 | Perclot, Floseal |
| Boehringer Ingelheim Pharmaceuticals, INC. | $81.55 | 2024-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $76.65 | 2025 | |
| Pfizer INC. | $75.37 | 2024 | |
| Actelion Pharmaceuticals US, INC. | $63.85 | 2025 | Uptravi, Opsumit |
| Alnylam Pharmaceuticals INC. | $54.41 | 2025 | Amvuttra |
| Bridgebio Pharma, INC. | $43.46 | 2025 | Attruby |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $42.54 | 2024 | Evkeeza |
| E.R. Squibb & Sons, L.L.C. | $40.12 | 2025 | Eliquis, Camzyos |
| Lsi Solutions INC | $39.97 | 2024 | Cor-Knot |
| Inspire Medical Systems, INC. | $34.98 | 2025 | Inspire |
| Astrazeneca Pharmaceuticals Lp | $30.16 | 2024 | Andexxa, Wainua |
| La Jolla Pharmaceutical Company | $26.39 | 2024 | Giapreza |
| Ethicon US, LLC | $24.53 | 2024 | Ethicon, Vistaseal, Stratafix |
| Abbott Laboratories | $21.54 | 2024 | Amplatzer Amulet |
| Boston Scientific Corporation | $21.04 | 2024 | Watchman Flx |
| Olympus America INC. | $20.35 | 2024 | Endoeye Flex Deflectable Videoscope |
| Bolton Medical INC | $18.47 | 2025 | Treo Abdominal Stent-Graft System |
| Janssen Pharmaceuticals, INC | $16.89 | 2024 | Xarelto |
| Lilly USA, LLC | $15.78 | 2025 | Zepbound, Mounjaro |
| Kls-Martin L.P. | $15.54 | 2024 | |
| Intuitive Surgical, INC. | $9.98 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Eton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.